America's Best Nonprofits
  1. Home
  2. Health Care
  3. Arlington, VA
  4. Idsa Education and Research Foundation

Idsa Education and Research Foundation

  • Arlington, VA
  • Tax-exempt since 2002
  • EIN: 31-1765388
idsafoundation.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate

Organization summary

Idsa Education and Research Foundation is a 501(c)(3) organization, classified under Health Care (NTEE E99). Contributions are tax-deductible.

4040 Wilson Blvd Ste 300, Arlington, VA 22203-4439

In fiscal year 2024 it reported $1,955,500 in revenue and $2,074,376 in expenses, with contributions making up 99.0% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

The idsa foundation, the 501(c)(3) Charitable arm of the infectious diseases society of America, complements idsa's mission by securing philanthropic and industry support to advance its strategic priorities. The foundation strengthens the infectious diseases workforce, promotes inclusion and equity, and expands idsa's capacity to lead in research, preparedness, and public health responseensuring lasting impact in the fight against infectious diseases.

Largest programs · fiscal year 2024

  • The microbial pathogenesis in alzheimer's disease program (alz/id) was launched to support innovativeresearch that may link infectious diseases and alzheimer's disease. This research includes basic,clinical and/or non-traditional research approaches across a wide range of disciplines including neurology, microbiology, pathology, virology, and bacteriology. In 2022, idsa foundation received grants… Read more

    The microbial pathogenesis in alzheimer's disease program (alz/id) was launched to support innovativeresearch that may link infectious diseases and alzheimer's disease. This research includes basic,clinical and/or non-traditional research approaches across a wide range of disciplines including neurology, microbiology, pathology, virology, and bacteriology. In 2022, idsa foundation received grants totaling $3.3 million to fund research awards for this program. In 2023, awards of approximately $2.5 million were granted to researchers, in addition to other incurred expenses related to the program. Due to the requirements of generally accepted accounting principles (gaap), the timing of the revenue and expense recognition created a large surplus in 2022 and a large deficit in 2023. In 2023, the program launched the first microbial pathogenesis in alzheimer's disease symposium, provided ongoing assistance and monitoring for existing grantees. No additional grants were issued in 2024, although additional funds are available for grants in 2025.

    $97,677 spent · 7.2% of program spending
  • G.e.r.m.germ - the germ program was developed to provide medical students with mentored clinical learningand/or research experience in infectious diseases-related topics, including HIV. In 2024, 75 people applied to the germ program and 40 $4,000 grants were awarded totaling $160,000. The goal of the g.e.r.m. Program is to increase interest among undergraduate medical students, particularly among… Read more

    G.e.r.m.germ - the germ program was developed to provide medical students with mentored clinical learningand/or research experience in infectious diseases-related topics, including HIV. In 2024, 75 people applied to the germ program and 40 $4,000 grants were awarded totaling $160,000. The goal of the g.e.r.m. Program is to increase interest among undergraduate medical students, particularly among populations underrepresented in medicine, in pursuing id fellowship post-graduate training or a career in HIV medicine by providing mentor-based research or clinical training; improving analytic, research and clinical skills of medical students; increasing the number and diversity of the id/HIV research and clinical workforce. Eligible applicants included first-, second-, and third year medical students and those in combined degree programs (md/mph, md/phd) from accredited allopathic or osteopathic medical schools in the U.S. Applications were reviewed and scored by an expert panel of infectious disease specialists.

    $215,728 spent · 15.9% of program spending
  • HIV clinical fellowship programhiv clinical fellowship program - the goal of the HIV clinical fellowship program is to provide non-id trained physicians with the most updated best practices for treating patients living with HIV. Clinical training includes management of antiretroviral therapy, treating common co-infectious and comorbidities and multidisciplinary team-based care. Fellows are support… Read more

    HIV clinical fellowship programhiv clinical fellowship program - the goal of the HIV clinical fellowship program is to provide non-id trained physicians with the most updated best practices for treating patients living with HIV. Clinical training includes management of antiretroviral therapy, treating common co-infectious and comorbidities and multidisciplinary team-based care. Fellows are supported for up to two years during which time they manage the care of a minimum of 30 patients, under the supervision of an HIV medical association mentor. In 2024, one fellow was funded with a $120,436 award.

    $125,962 spent · 9.3% of program spending
  • Idea incubatorthe idea incubator program is a pitch-style competition for innovations in the field of infectious diseases. The program encourages innovators with original inventions, products and ideas that can improve infectious disease care to apply. Innovations are shared with the id community and judged by individuals from businesses, medical and technology fields. Three winning individuals/te… Read more

    Idea incubatorthe idea incubator program is a pitch-style competition for innovations in the field of infectious diseases. The program encourages innovators with original inventions, products and ideas that can improve infectious disease care to apply. Innovations are shared with the id community and judged by individuals from businesses, medical and technology fields. Three winning individuals/teams are selected from those that apply. Finalists present their innovations at the annual idweek conference and were awarded a total of $35,000 in cash prizes. For 2024, the winner was awarded $15,000, and second and third prizes were awarded $10,000 each.

    $76,142 spent · 5.6% of program spending
  • Mentorshipthe idweek mentorship program offers opportunities for mentorship and networking through one-on-one interactions between leaders in the field and fellows, residents and medical students during idweek. $174,819 spent · 12.9% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 65¢ went to programs, 27¢ to management and 8¢ to fundraising.

  • Programs $1,353,204
  • Management $551,856
  • Fundraising $169,316

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$1,955,500Fiscal year 20242022: $6,109,82820222023: $2,808,76320232024: $1,955,5002024
Expenses$2,074,376Fiscal year 20242022: $3,927,17620222023: $5,200,88320232024: $2,074,3762024
Total assets$952,034Fiscal year 20242022: $3,202,71820222023: $956,56520232024: $952,0342024
Total liabilities$658,173Fiscal year 20242022: $397,86120222023: $543,82820232024: $658,1732024
Fiscal year ending December 2024
Revenue$1,955,500
Expenses$2,074,376
Net income−$118,876
Net assets$293,861

Notable sources of revenue

Percent of total revenue
Contributions$1,935,036
Program services$0
Investment income$20,464
Other (net)$0

Assets / debt

Total assets$952,034
Total liabilities$658,173
Net assets$293,861

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$2,808,763
Expenses$5,200,883
Net income−$2,392,120
Net assets$412,737

Notable sources of revenue

Percent of total revenue
Contributions$2,785,073
Program services$0
Investment income$23,690
Other (net)$0

Assets / debt

Total assets$956,565
Total liabilities$543,828
Net assets$412,737

Compensation

Officers and key employees$146,745
Share of expenses2.8%
Fiscal year ending December 2022
Revenue$6,109,828
Expenses$3,927,176
Net income$2,182,652
Net assets$2,804,857

Notable sources of revenue

Percent of total revenue
Contributions$6,084,127
Program services$0
Investment income$25,701
Other (net)$0

Assets / debt

Total assets$3,202,718
Total liabilities$397,861
Net assets$2,804,857

Compensation

Officers and key employees$258,684
Share of expenses6.6%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?